("APASL COVID Liver Injury Spectrum")
During this pandemic, the hepatology community is concerned whether their chronic liver disease/cirrhosis patients who get infected with COVID-19, do decompensate or not.
To study the Liver Injury due to COVID-19 infection, we need to record the course and outcome of each of such patients.
We have prepared a brief survey to address this under the Task Force of APASL. If you would like to share your individual patient data, please use the monkey survey.
Each patient data needs to be filled separately, and would take just about 5 minutes.
The manuscript policy will be as per international norms.
Do join the “APCOLIS STUDY” of APASL using this web-link. (Clinical Trial Identifier-NCT.)
Dr. Shiv. K. Sarin, MD, DM
On behalf of APASL